0 references
Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report
Viral Hepatitis Journal2014Vol. 20(2), pp. 81–84
Abstract
1Buldan Chest Diseases Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Denizli, Turkey 2Harran University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sanliurfa, Turkey 3Yozgat Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Yozgat, Turkey Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/ Ribavirin+Telaprevir: A Case Report
Related Papers
- → Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner(2014)12 cited
- → A new era in the treatment of chronic hepatitis C infection(2012)5 cited
- → Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy(2015)3 cited
- → Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report(2014)
- → Sa1077 Telaprevir-Interferon-Ribavirin Trio Versus Interferon-Ribavirin Duo Therapy for Chronic Hepatitis C: A Sequential Analysis of Randomized Control Trials(2012)